1/41
Comprehensive vocabulary flashcards covering cardiovascular anatomy, cardiac electrophysiology, hemodynamic parameters, diagnostic markers, hypertension, vascular diseases, myocardial infarction, and congestive heart failure.

Human Circulatory System
A dual-circuit circulatory network where the right side of the heart receives deoxygenated blood and pumps it to the lungs, and the left side receives oxygenated blood from the lungs and pumps it to the rest of the body.
Epicardium
The outermost layer of the heart wall; the prefix "epi" means "upon."
Myocardium
The thick middle muscular layer of the heart wall responsible for contraction; "myo" means "muscle."
Endocardium
The smooth inner epithelial layer lining the chambers and valves of the heart; "endo" means "within."

Cardiac Conduction System
The network of specialized neuromuscular tissue that coordinates heart contractions, comprising the SA node, AV node, Bundle of His, right and left bundle branches, and Purkinje fibers.
Sodium (Na+) in Cardiac Electrophysiology
The electrolyte responsible for Phase 0 (rapid depolarization) of the cardiac action potential; when fast sodium channels open, sodium rushes into myocardiocytes, converting cellular potential from negative to positive.
Potassium (K+) in Cardiac Electrophysiology
The electrolyte responsible for Phase 3 (repolarization) and maintaining Phase 4 (resting membrane potential); potassium exits the cell to restore internal negative charge so it can reset for the subsequent beat.
Calcium (Ca2+) in Cardiac Electrophysiology
The electrolyte driving Phase 2 (plateau phase) that enables myocardial contractility; extracellular calcium influx triggers further calcium release from the sarcoplasmic reticulum, permitting actin and myosin to slide.
Magnesium (Mg2+) in Cardiac Electrophysiology
An electrolyte that acts as a cofactor for the Na+/K+-ATPase pump, regulates calcium influx, stabilizes myocardial cell membranes, and prevents lethal ventricular arrhythmias.
Cardiac Action Potential: Phase 0
The rapid depolarization phase triggered by the rapid inflow of sodium into myocardial cells.
Cardiac Action Potential: Phase 1
The early partial repolarization phase characterized by a transient outflow of potassium.
Cardiac Action Potential: Phase 2
The plateau phase of the cardiac action potential, where the inward movement of calcium is balanced by the outward movement of potassium.
Cardiac Action Potential: Phase 3
The rapid repolarization phase driven by the sustained outflow of potassium.
Cardiac Action Potential: Phase 4
The resting membrane potential phase during which the Na+/K+-ATPase pump restores baseline electrolyte gradients.
Systole
The contraction phase of the heart muscle during which blood is pumped into the circulation.
Diastole
The relaxation phase of the myocardium during which the ventricles fill with blood.
Cardiac Output (CO)
The total volume of blood ejected by each ventricle per minute.
Cardiac Index (CI)
A hemodynamic parameter that adjusts cardiac output relative to individual body surface area.
Preload
The volume of blood present within the ventricles at the end of diastole immediately before the subsequent contraction.
Afterload
The peripheral resistance or opposing pressure against which the left ventricle must pump to eject blood.
Mean Arterial Pressure (MAP)
The average pressure maintained within the arterial system that is delivered to perfuse organs in the body.
Pulse Pressure
The numerical difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP).
Cardiac Murmur
An unusual, extra sound heard on cardiac auscultation produced by turbulent blood flow; primarily caused by stenosis, regurgitation, structural defects, or high blood flow.

Cardiac Auscultation Sites (A-P-E-T-M)
The five standard anatomical chest landmarks for heart sounds: Aortic (Right 2nd Intercostal Space), Pulmonic (Left 2nd Intercostal Space), Erb's point (Left 3rd Intercostal Space), Tricuspid (Lower left sternal border 4th Intercostal Space), and Mitral (Left 5th Intercostal Space, medial to midclavicular line).
Troponin I or T
The gold-standard cardiac biomarker for myocardial infarction; elevates within 3–4hrs, stays elevated for 7–14days, and has a normal reference value of <0.05ng/mL.
CK-MB
A cardiac enzyme specific to myocardial damage; elevates within 4–6hrs, peaks in 18–24hrs, and has a normal reference value of <5ng/mL.
Brain Natriuretic Peptide (BNP)
A hormone released in response to stretching of ventricular walls caused by fluid overload; normal reference value is <100pg/mL.
Primary Hypertension
Essential or idiopathic elevation of systemic blood pressure occurring without an identified medical cause; accounts for 90–95% of all hypertension cases.
Secondary Hypertension
Elevation of blood pressure resulting from an identifiable and correctable underlying cause; accounts for 5–10% of hypertension cases.
Hypertensive Emergency
Severe blood pressure elevation (SBP>180mmHg and/or DBP>120mmHg) accompanied by active target organ damage; associated with a 79% mortality rate and mandates hospitalization.
Hypertensive Urgency
Severe blood pressure elevation (SBP>180mmHg and/or DBP>120mmHg) occurring without evidence of target organ disease; more common and typically managed without mandatory admission.
Peripheral Artery Disease (PAD)
Progressive narrowing and degeneration of peripheral arteries (chiefly in lower limbs) causing inadequate arterial tissue perfusion; manifestations include intermittent claudication, diminished pulses, pale/cool skin, and deep punched-out ulcers.
Peripheral Vascular Disease (PVD)
Inadequacy of venous valves preventing proper return of blood to the heart and leading to venous stasis; manifestations include dull aching pain worsened by prolonged standing, moderate-to-severe edema, brownish skin, and shallow irregular ulcers.
Raynaud's Disease (Primary Raynaud's)
An idiopathic condition characterized by digital vasospastic episodes causing color changes (white to blue to red) in response to cold or emotional stress without an underlying medical illness.
Raynaud's Phenomenon (Secondary Raynaud's)
Digital vasospasms and color changes occurring secondary to an underlying systemic or autoimmune condition, such as Systemic Lupus Erythematosus (SLE).
Buerger's Disease (Thromboangiitis Obliterans)
An inflammatory, non-atherosclerotic occlusive disorder of small- and medium-sized arteries and veins in the extremities, strongly associated with heavy tobacco use in young males (<45 years old).

Coronary Artery Disease (CAD)
A pathological condition characterized by the accumulation of atherosclerotic plaques within the coronary arteries, restricting arterial blood flow and oxygen delivery to the myocardium.
Myocardial Infarction (MI)
Ischemia and necrosis of myocardial tissue characterized clinically by "CRUSHING" manifestations (chest pain, radiating pain, unrelieved by nitroglycerin, sweating, dyspnea, increased vitals, nausea, feeling of impending doom).
MONA Protocol
The primary medical management acronym for acute myocardial infarction, consisting of Morphine, Oxygen, Nitroglycerin, and Aspirin.
Congestive Heart Failure (CHF)
A complex clinical syndrome in which the heart is unable to pump blood efficiently to satisfy the metabolic demands of body tissues, leading to systemic or pulmonary venous congestion.
Left-Sided Heart Failure
Failure of the left ventricle to empty adequately during systole or fill during diastole, presenting with pulmonary congestion symptoms ("FORCED": Fatigue, Orthopnea, Rales/crackles, Cough with pink frothy sputum, Exertional dyspnea, Dyspnea & PND).
Right-Sided Heart Failure
Ineffective pumping of the right ventricle leading to systemic venous backpressure, presenting with systemic congestion signs ("SWELLING": Splenomegaly/hepatomegaly, Weight gain, Edema, increased JVD, Large abdominal girth, Nocturia, GI distress).